These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 25592041

  • 1. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
    Cao LQ, Shao ZL, Liang HH, Zhang DW, Yang XW, Jiang XF, Xue P.
    Cancer Lett; 2015 Apr 01; 359(1):127-35. PubMed ID: 25592041
    [Abstract] [Full Text] [Related]

  • 2. PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
    Shen B, Chu ES, Zhao G, Man K, Wu CW, Cheng JT, Li G, Nie Y, Lo CM, Teoh N, Farrell GC, Sung JJ, Yu J.
    Br J Cancer; 2012 Apr 24; 106(9):1486-94. PubMed ID: 22472882
    [Abstract] [Full Text] [Related]

  • 3. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR, Choi HN, Lee HJ, Baek HA, Park HS, Jang KY, Chung MJ, Moon WS.
    Oncol Rep; 2007 Oct 24; 18(4):825-32. PubMed ID: 17786342
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor-γ inhibits pancreatic cancer cell invasion and metastasis via regulating MMP-2 expression through PTEN.
    Li Y, Zhang DW, Lin DQ, Cao LQ.
    Mol Med Rep; 2015 Oct 24; 12(4):6255-60. PubMed ID: 26299428
    [Abstract] [Full Text] [Related]

  • 5. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
    Cheung KF, Zhao J, Hao Y, Li X, Lowe AW, Cheng AS, Sung JJ, Yu J.
    Cancer; 2013 Mar 15; 119(6):1217-26. PubMed ID: 23212831
    [Abstract] [Full Text] [Related]

  • 6. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.
    Han M, Gao H, Ju P, Gao MQ, Yuan YP, Chen XH, Liu KL, Han YT, Han ZW.
    Biomed Pharmacother; 2018 Jul 15; 103():272-283. PubMed ID: 29656183
    [Abstract] [Full Text] [Related]

  • 7. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J, Kim BH, Kim YI, Kim KY, Hwangbo Y, Jang JY, Dong SH, Kim HJ, Chang YW, Chang R.
    Int J Oncol; 2010 Jan 15; 36(1):223-31. PubMed ID: 19956851
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
    Yu J, Shen B, Chu ES, Teoh N, Cheung KF, Wu CW, Wang S, Lam CN, Feng H, Zhao J, Cheng AS, To KF, Chan HL, Sung JJ.
    Hepatology; 2010 Jun 15; 51(6):2008-19. PubMed ID: 20512989
    [Abstract] [Full Text] [Related]

  • 9. Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.
    Yang Y, Zhao LH, Huang B, Wang RY, Yuan SX, Tao QF, Xu Y, Sun HY, Lin C, Zhou WP.
    Mol Carcinog; 2015 Dec 15; 54(12):1584-95. PubMed ID: 25307746
    [Abstract] [Full Text] [Related]

  • 10. Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma.
    Hsu HT, Sung MT, Lee CC, Kuo YJ, Chi CW, Lee HC, Hsia CY.
    Int J Mol Sci; 2016 Jul 29; 17(8):. PubMed ID: 27483249
    [Abstract] [Full Text] [Related]

  • 11. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells.
    Cellai I, Benvenuti S, Luciani P, Galli A, Ceni E, Simi L, Baglioni S, Muratori M, Ottanelli B, Serio M, Thiele CJ, Peri A.
    Br J Cancer; 2006 Oct 09; 95(7):879-88. PubMed ID: 16969347
    [Abstract] [Full Text] [Related]

  • 12. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS, Chen WC, Bai X, Wang YD.
    J Dig Dis; 2007 May 09; 8(2):82-8. PubMed ID: 17532820
    [Abstract] [Full Text] [Related]

  • 13. Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1.
    Pang X, Wei Y, Zhang Y, Zhang M, Lu Y, Shen P.
    Cancer Sci; 2013 Jun 09; 104(6):672-80. PubMed ID: 23461356
    [Abstract] [Full Text] [Related]

  • 14. Functional role of peroxisome-proliferator-activated receptor γ in hepatocellular carcinoma.
    Wu CW, Farrell GC, Yu J.
    J Gastroenterol Hepatol; 2012 Nov 09; 27(11):1665-9. PubMed ID: 22742931
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.
    Schaefer KL, Wada K, Takahashi H, Matsuhashi N, Ohnishi S, Wolfe MM, Turner JR, Nakajima A, Borkan SC, Saubermann LJ.
    Cancer Res; 2005 Mar 15; 65(6):2251-9. PubMed ID: 15781638
    [Abstract] [Full Text] [Related]

  • 16. Activation of peroxisome proliferator-activated receptor-gamma inhibits tumor growth by negatively regulating nuclear factor-κB activation in patients with hepatocellular carcinoma.
    Nojima H, Kuboki S, Shinoda K, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Takayashiki T, Miyazaki M.
    J Hepatobiliary Pancreat Sci; 2016 Sep 15; 23(9):574-84. PubMed ID: 27451128
    [Abstract] [Full Text] [Related]

  • 17. Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma.
    Vara D, Morell C, Rodríguez-Henche N, Diaz-Laviada I.
    Cell Death Dis; 2013 May 02; 4(5):e618. PubMed ID: 23640460
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor.
    Zhou L, Wang DS, Li QJ, Sun W, Zhang Y, Dou KF.
    Oncol Rep; 2012 Sep 02; 28(3):874-82. PubMed ID: 22736202
    [Abstract] [Full Text] [Related]

  • 19. Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-κB-TAK1-ERK1/2 axis in the context of PPARγ agonistic activity.
    Saber S, Khodir AE, Soliman WE, Salama MM, Abdo WS, Elsaeed B, Nader K, Abdelnasser A, Megahed N, Basuony M, Shawky A, Mahmoud M, Medhat R, Eldin AS.
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec 02; 392(12):1591-1604. PubMed ID: 31367864
    [Abstract] [Full Text] [Related]

  • 20. [Role of histone deacetylase in inhibiting invasion of human gastric carcinoma cell line SGC-7901 by PPARgamma-mediated pathway].
    Ma GD, Zhang CQ, Hou J, Zhang LY, Lin C.
    Ai Zheng; 2009 Jul 02; 28(7):695-701. PubMed ID: 19624894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.